Cialis Interactions with Other Drugs

See Telstra Corporation Limited v. Telsra/Telecomunicaciones Serafin Rodriguez y Asociados, D2003-0247 (WIPO, July 21, 2003) (determined that since the mark TELSTRA is an invented word and given its nature, widespread advertisement and exposure to consumers worldwide, the mark is highly distinctive).� A domain name which differs very slightly from a trademark has a greater tendency to be confusingly similar where that trademark is highly distinctive.� See Credit Suisse Group v. VPDD UBGM ltd, D2007-0867 (WIPO, September 10, 2007).� �� (3)��� The Domain Names are confusingly similar to the CIALIS mark. The Domain Names are confusing similar to Complainant�s CIALIS mark.� The addition of generic or descriptive words such as "buy," "cheap," and "generic," to Complainant's highly distinctive CIALIS trademark does not prevent a finding of confusing similarity.� Prior Forum Panels have noted that, "the mere addition of a generic or descriptive abbreviation to a registered mark does not negate the confusing similarity of respondent's domain name. "� Lilly ICOS LLC v. Joe Pestrak, FA 0504000464558 (NAF, May 31, 2005).� As a result, the addition of generic or descriptive words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark.� See Lilly ICOS LLC v.

• Cialis is a medication used to treat erectile dysfunction.
• Cialis contains the active ingredient tadalafil.
• It is available by prescription at pharmacies.
• Cialis helps improve blood flow to the penis.
• The usual dose is 10mg or 20mg before activity.
• Cialis can be taken with or without food.
• The effects of Cialis last up to 36 hours.
• Common side effects include headache and flushing.
• Cialis is not suitable for everyone; consult a doctor first.
• It may interact with nitrates and other medications.
• Cialis can be purchased online with a valid prescription.
• Always follow the dosage instructions given by your pharmacist.

Andrew Riegel, FA0609000788279 (NAF, October 18, 2006) (finding the addition of the generic term "buy" to Complainant's CIALIS mark did not overcome the confusing similarity between the disputed domain name and the CIALIS mark); Lilly ICOS LLC v. Jay Kim, D2004-0891 (WIPO, January 28, 2005) (finding the addition of the generic word "generic" and the generic letter "a" to Complainant's CIALIS mark did not prevent the domain name from being confusingly similar to the CIALIS mark); and Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (determining that the addition of the words "drug", "online", "buying" and "guide" to Complainant's registered CIALIS trademark did not eliminate the confusing similarity between the CIALIS mark and the domain name because the additional words did not distinguish the owner of the disputed name from Complainant).� In the present case, Respondents have merely added generic and/or descriptive words and phrases to the CIALIS mark in the Domain Names.� Respondents� addition of these words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark. Additionally, when a domain name incorporates a distinctive mark in its entirety that creates sufficient similarity between a mark and a domain name to render the domain name confusingly similar.� EAuto v.

Are There Alternative Names for the Brand and Generic Cialis?

Doctor Preferences

Comparison Table

Triple S.

Auto Parts, D2000-0047 (WIPO, March 24, 2000).� In the case at hand, the Domain Names are confusingly similar to the CIALIS mark because they incorporate the mark cialis super aktiv in its entirety.� See Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (finding that the disputed domain name was confusingly similar to the CIALIS trademark because it incorporated the distinctive CIALIS mark in its entirety) (Annex 3, N).� With the exception of the generic and/or descriptive words and phrases, the Domain Names consist of Complainant's CIALIS mark in its entirety.� Thus, the Domain Names are confusingly similar to Complainant's CIALIS trademark.

• Traveling with prescription medication requires planning, especially for international travel.
• Keep Cialis in its original pharmacy-labeled container to avoid issues with security or customs.
• Carry a copy of your prescription or a letter from your doctor, particularly when traveling abroad.
• Check the legal status of tadalafil in your destination country, as laws can vary.
• Do not pack your medication in checked luggage; always keep it in your carry-on bag.
• Temperature extremes in cargo holds can degrade the medication's effectiveness.
• Plan for time zone changes if you are on a daily dosing schedule; adjust timing gradually.
• Ensure you have an adequate supply for the entire trip plus a few extra days in case of delays.
• Know how to contact a doctor or find a pharmacy at your destination if needed.
• Travel insurance that covers medical care and prescription refills can provide peace of mind.

]������� The Respondents have no rights or legitimate interests in respect of the Domain Names. ����������� �� (1)��� Respondents are not using the Domain Names for a legitimate business purpose. Respondents have no rights or legitimate interests in the Domain Names.� There is no evidence that the Respondents have been commonly known by the term "CIALIS" or any of the corresponding Domain Names.� All of the active websites associated with the Domain Names resolve to the same networks which promote and allegedly sell �Generic� CIALIS brand product, which have not been approved by the U.S. Food and Drug Administration ("FDA") or any other health authority and are unlawful pharmaceutical products.� To date, there is no "generic" version of CIALIS brand product approved by the FDA or any other health authority.� As a result, any "generic" CIALIS product is an unlawful, counterfeit pharmaceutical product.�� By using the mark CIALIS in the Domain Names, the Respondents are luring consumers in search of Complainant's CIALIS brand product to websites that promote "generic" and brand name pharmaceutical products, including products which are arguably competitive with Complainant's CIALIS product.� Such use does not demonstrate a legitimate right or interest in the Domain Names.

• Disposal of unused or expired medication should be done properly to ensure safety.
• The best way to dispose of most medicines is through a drug take-back program.
• Many pharmacies and community organizations host take-back events or have permanent drop boxes.
• If a take-back program is not available, follow the FDA's recommended steps for disposal.
• Mix the medicine (do not crush) with an unappealing substance like dirt, kitty litter, or coffee grounds.
• Place the mixture in a sealed plastic bag and throw it away in your household trash.
• Before throwing out the empty pill bottle, scratch out all personal information on the label.
• Flushing medication down the toilet is only recommended for a small list of drugs with high abuse potential.
• Tadalafil is not on the FDA's flush list, so it should not be disposed of in this manner.
• Proper disposal prevents accidental ingestion, misuse, and helps protect the environment.

See Eli Lilly buy cialis online no prescription canada and Company v.

Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (finding that using the disputed domain names to redirect to websites advertising and promoting competing products is not consistent with a bona fide offering of goods and services under Policy �4(c)(i) or a legitimate noncommercial or fair use according to Policy �4(c)(iii)) (Annex 3, P) and Lilly ICOS LLC v. Alexey Stoun, D2006-1170 (WIPO, November 16, 2006) (finding that the registrant did not have any legitimate right or interest in the disputed domain because registrant was using the mark CIALIS in the domain at issue to direct consumers in search of CIALIS brand product to a website which advertised "generic" CIALIS product as well as competitive products).� While approximately 10 of the websites associated with the Domain Names are not currently active, it is apparent from the Respondents� use of the �active� Domain Names that all of the Domain Names have been registered and are being used in bad faith.� Prior panels have held that even passive holding of a domain name can constitute bad faith use and registration.� In Telstra Corporation Limited v. Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000), WIPO recognized that a respondent's inaction (e.g. passive holding) could represent bad faith use of a domain name under certain circumstances.� The decision noted that the determination as to what circumstances constituted "certain circumstances" worthy of a bad faith determination would be fact specific to each case.� In Telstra, some of the particular circumstances leading to a finding of bad faith included: (1) complainant's mark had a strong reputation and was widely known; (2) respondent failed to show any evidence of actual or contemplated good faith use by it of the domain name; and (3) it was impossible to conceive of any plausible actual or contemplated active use of the domain name by respondent that would not be illegitimate, such as being a passing off, an infringement of consumer protection legislation, or trademark infringement.� Such factors are present in the case at hand.� As set forth in detail above, Complainant's CIALIS mark has a strong reputation and is widely known throughout the world.� In addition, Respondents have no apparent rights or legitimate interest in the Domain Names.� As described above, Respondents are using Complainant's CIALIS trademark in other domain names to attract Internet consumers to its websites, which are online pharmacies advertising and selling counterfeit versions of Complainant�s CIALIS brand product in violation of Complainant�s intellectual property rights and various national laws concerning the sale of pharmaceuticals.� With respect to the few �inactive� Domain Names, there is no plausible use of the associated websites by Respondents that would not be illegitimate.� Respondents� registration of multiple domain names which incorporate Complainant's distinctive CIALIS mark further demonstrates Respondents� improper conduct.� In light of these factors, Respondents' "passive holding" of some of the Domain Names amounts to use in bad faith.

Moreover, as previous Panels have held, "rights or legitimate interests cannot be created where the user of the domain name at issue would not choose such a name unless he was seeking to create an impression of association with the complainant." See Eli Lilly and Company v.

What Dosages and Forms is Cialis available in?

Payment Methods

User Reviews

media/broadcasting, Lee Shung, D2010-1079 (WIPO, September 14, 2010) (determining that the respondent did not have any right or legitimate interest in the domain <36cialis.com> where the respondent sold unauthorized or counterfeit products of the complainant).� Respondents clearly chose the Domain Names in order to create an impression of association with Complainant and Complainant's well-known CIALIS mark.� In light of these factors, it is apparent from the websites associated with the Domain Names that the Respondents are attempting to capitalize on the valuable reputation and goodwill of the CIALIS mark to direct Internet users to its websites.�� � ���(2)� Respondents are not authorized by Complainant to use the CIALIS trademark. Complainant has not given Respondents permission, authorization, consent or license to use its CIALIS mark.� Despite this fact, however, the Domain Names resolve to websites enabling the Respondents to benefit from the strength of Complainant's CIALIS mark and the reputation and goodwill of the product with which the mark is associated. [c.]��������� The Domain Names were registered and are being used in bad faith.

• Purchase Cialis only from licensed pharmacies.
• Verify the medication’s packaging for authenticity.
• Beware of counterfeit Cialis sold online.
• Store Cialis in a cool, dry place.
• Keep Cialis out of reach of children.
• Do not use Cialis if you have heart issues.
• Discuss your medical history before use.
• Report any adverse reactions to your doctor.
• Cialis is contraindicated with certain medications.
• Do not exceed the prescribed dosage.
• Be aware of possible side effects like dizziness.
• Consult your doctor for proper usage guidance.

Complainant has a June 17, 1999 constructive use date of the CIALIS trademark based upon its U.S.

What is Cialis used for?

Respondents have no rights or legitimate interests in the Domain Names.� There is no evidence that the Respondents have been commonly known by the term "CIALIS" or any of the corresponding Domain Names.� All of the active websites associated with the Domain Names resolve to the same networks which promote and allegedly sell �Generic� CIALIS brand product, which have not been approved by the U.S. Food and Drug Administration ("FDA") or any other health authority and are unlawful pharmaceutical products.� To date, there is no "generic" version of CIALIS brand product approved by the FDA or any other health authority.� As a result, any "generic" CIALIS product is an unlawful, counterfeit pharmaceutical product.�� By using the mark CIALIS in the Domain Names, the Respondents are luring consumers in search of Complainant's CIALIS brand product to websites that promote "generic" and brand name pharmaceutical products, including products which are arguably competitive with Complainant's CIALIS product.� Such use does not demonstrate a legitimate right or interest in the Domain Names. See Eli Lilly buy cialis online no prescription canada and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (finding that using the disputed domain names to redirect to websites advertising and promoting competing products is not consistent with a bona fide offering of goods and services under Policy �4(c)(i) or a legitimate noncommercial or fair use according to Policy �4(c)(iii)) (Annex 3, P) and Lilly ICOS LLC v. Alexey Stoun, D2006-1170 (WIPO, November 16, 2006) (finding that the registrant did not have any legitimate right or interest in the disputed domain because registrant was using the mark CIALIS in the domain at issue to direct consumers in search of CIALIS brand product to a website which advertised "generic" CIALIS product as well as competitive products).� While approximately 10 of the websites associated with the Domain Names are not currently active, it is apparent from the Respondents� use of the �active� Domain Names that all of the Domain Names have been registered and are being used in bad faith.� Prior panels have held that even passive holding of a domain name can constitute bad faith use and registration.� In Telstra Corporation Limited v.

Pharmacy Availability

Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000), WIPO recognized that a respondent's inaction (e.g. passive holding) could represent bad faith use of a domain name under certain circumstances.� The decision noted that the determination as to what circumstances constituted "certain circumstances" worthy of a bad faith determination would be fact specific to each case.� In Telstra, some of the particular circumstances leading to a finding of bad faith included: (1) complainant's mark had a strong reputation and was widely known; (2) respondent failed to show any evidence of actual or contemplated good faith use by it of the domain name; and (3) it was impossible to conceive of any plausible actual or contemplated active use of the domain name by respondent that would not be illegitimate, such as being a passing off, an infringement of consumer protection legislation, or trademark infringement.� Such factors are present in the case at hand.� As set forth in detail above, Complainant's CIALIS mark has a strong reputation and is widely known throughout the world.� In addition, Respondents have no apparent rights or legitimate interest in the Domain Names.� As described above, Respondents are using Complainant's CIALIS trademark in other domain names to attract Internet consumers to its websites, which are online pharmacies advertising and selling counterfeit versions of Complainant�s CIALIS brand product in violation of Complainant�s intellectual property rights and various national laws concerning the sale of pharmaceuticals.� With respect to the few �inactive� Domain Names, there is no plausible use of the associated websites by Respondents that would not be illegitimate.� Respondents� registration of multiple domain names which incorporate Complainant's distinctive CIALIS mark further demonstrates Respondents� improper conduct.� In light of these factors, Respondents' "passive holding" of some of the Domain Names amounts to use in bad faith. Moreover, as previous Panels have held, "rights or legitimate interests cannot be created where the user of the domain name at issue would not choose such a name unless he was seeking to create an impression of association with the complainant." See Eli Lilly and Company v. media/broadcasting, Lee Shung, D2010-1079 (WIPO, September 14, 2010) (determining that the respondent did not have any right or legitimate interest in the domain <36cialis.com> where the respondent sold unauthorized or counterfeit products of the complainant).� Respondents clearly chose the Domain Names in order to create an impression of association with Complainant and Complainant's well-known CIALIS mark.� In light of these factors, it is apparent from the websites associated with the Domain Names that the Respondents are attempting to capitalize on the valuable reputation and goodwill of the CIALIS mark to direct Internet users to its websites.�� � ���(2)� Respondents are not authorized by Complainant to use the CIALIS trademark. Complainant has not given Respondents permission, authorization, consent or license to use its CIALIS mark.� Despite this fact, however, the Domain Names resolve to websites enabling the Respondents to benefit from the strength of Complainant's CIALIS mark and the reputation and goodwill of the product with which the mark is associated.

Black Box Warnings

[c.]��������� The Domain Names were registered and are being used in bad faith. Complainant has a June 17, 1999 constructive use date of the CIALIS trademark based upon its U.S. trademark rights.� Media coverage of the CIALIS brand product is dated as early as 2001.� Complainant has extensively marketed and advertised its pharmaceutical product using the CIALIS trademark.� Therefore, because it is reasonable to infer that the CIALIS trademark is well-known, it is highly likely that the Respondents knew of Complainant's CIALIS mark at the time of registering over 70 confusingly similar Domain Names. According to Policy �4(b)(ii), evidence of bad faith registration and use is shown when a respondent has registered a domain name in order to prevent the trademark owner from reflecting the mark in a corresponding domain name, provided the respondent has engaged in a pattern of such conduct.�� See Eli Lilly and Company v. trademark rights.� Media coverage of the CIALIS brand product is dated as early as 2001.� Complainant has extensively marketed and advertised its pharmaceutical product using the CIALIS trademark.� Therefore, because it is reasonable to infer that the CIALIS trademark is well-known, it is highly likely that the Respondents knew of Complainant's CIALIS mark at the time of registering over 70 confusingly similar Domain Names.

International Nonproprietary Name And Brand Names

See Telstra Corporation Limited v. Telsra/Telecomunicaciones Serafin Rodriguez y Asociados, D2003-0247 (WIPO, July 21, 2003) (determined that since the mark TELSTRA is an invented word and given its nature, widespread advertisement and exposure to consumers worldwide, the mark is highly distinctive).� A domain name which differs very slightly from a trademark has a greater tendency to be confusingly similar where that trademark is highly distinctive.� See Credit Suisse Group v. VPDD UBGM ltd, D2007-0867 (WIPO, September 10, 2007).� �� (3)��� The Domain Names are confusingly similar to the CIALIS mark. The Domain Names are confusing similar to Complainant�s CIALIS mark.� The addition of generic or descriptive words such as "buy," "cheap," and "generic," to Complainant's highly distinctive CIALIS trademark does not prevent a finding of confusing similarity.� Prior Forum Panels have noted that, "the mere addition of a generic or descriptive abbreviation to a registered mark does not negate the confusing similarity of respondent's domain name. "� Lilly ICOS LLC v.

Feedback from Forums

Joe Pestrak, FA 0504000464558 (NAF, May 31, 2005).� As a result, the addition of generic or descriptive words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark.� See Lilly ICOS LLC v. Andrew Riegel, FA0609000788279 (NAF, October 18, 2006) (finding the addition of the generic term "buy" to Complainant's CIALIS mark did not overcome the confusing similarity between the disputed domain name and the CIALIS mark); Lilly ICOS LLC v. Jay Kim, D2004-0891 (WIPO, January 28, 2005) (finding the addition of the generic word "generic" and the generic letter "a" to Complainant's CIALIS mark did not prevent the domain name from being confusingly similar to the CIALIS mark); and Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (determining that the addition of the words "drug", "online", "buying" and "guide" to Complainant's registered CIALIS trademark did not eliminate the confusing similarity between the CIALIS mark and the domain name because the additional words did not distinguish the owner of the disputed name from Complainant).� In the present case, Respondents have merely added generic and/or descriptive words and phrases to the CIALIS mark in the Domain Names.� Respondents� addition of these words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark. Additionally, when a domain name incorporates a distinctive mark in its entirety that creates sufficient similarity between a mark and a domain name to render the domain name confusingly similar.� EAuto v.

Common Alternatives

Triple S. Auto Parts, D2000-0047 (WIPO, March 24, 2000).� In the case at hand, the Domain Names are confusingly similar to the CIALIS mark because they incorporate the mark cialis super aktiv in its entirety.� See Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (finding that the disputed domain name was confusingly similar to the CIALIS trademark because it incorporated the distinctive CIALIS mark in its entirety) (Annex 3, N).� With the exception of the generic and/or descriptive words and phrases, the Domain Names consist of Complainant's CIALIS mark in its entirety.� Thus, the Domain Names are confusingly similar to Complainant's CIALIS trademark. ]������� The Respondents have no rights or legitimate interests in respect of the Domain Names. ����������� �� (1)��� Respondents are not using the Domain Names for a legitimate business purpose. According to Policy �4(b)(ii), evidence of bad faith registration and use is shown when a respondent has registered a domain name in order to prevent the trademark owner from reflecting the mark in a corresponding domain name, provided the respondent has engaged in a pattern of such conduct.�� See Eli Lilly and Company v.